《仲量联行:房地产视角下的美国生命科学产业(2023)(30页).pdf》由会员分享,可在线阅读,更多相关《仲量联行:房地产视角下的美国生命科学产业(2023)(30页).pdf(30页珍藏版)》请在三个皮匠报告上搜索。
1、 122023F.S.2023122023Travis McC 20242202432021 100-200260%260112 2556P 2020212202021-%-40%2023202420217P 202312282861(IPO)1620232013-20148P 2023ETFXBINBI1BioPharmAnalyst20233002024#92P 2022020212500 202310002023 3000082%65
2、% 370063%-/10%20192022200 10% Pillar5010%-15%0221127000 202320232023562023L 20232023202262023202413%11%6%5%3%3%3%2%1%1%52%155L 40% 18100(Mission Bay)/(China Basin)AREBMRPEAK356/MetaAREBMR100/1030023% 10- 23,43332,07429,17328,95310,37617,493.403,315.401,902.701,
3、051.40528.7020223.4.1.5.2.- Surgical)10084.736.4(Agilent Technologies)39.5-/3M-Colder ProductsJunoPacific/CretexStarkey15,000STEMSalt Lake CityMinneapolis-St.PaulGreater BostonOrange CountySF Bay A 2-324,42819,69617,83016,3379,8482022年医药制造业就业数 CDMOElevateBioNational Resilience(Catalent)(Lonza)cGMP400CGTWuXIATUCTDMO140,000 Center for Breakthrough Medicines300Spark Therapeutics505.75CMO(Gilead)Personalis(AlexzaPharmaceuticals)CMO-(Research Triangle Park)SF Bay AreaNew JerseyRaleigh-DurhamGreater BostonP 2720242020- 200JLL 55060/